Pandemic Produces New Stimulus To Develop Universal Vaccine, Create Better Defenses Against Flu Mutations Of The Future
This article was originally published in PharmAsia News
Executive Summary
BEIJING - The first pandemic to threaten the planet in decades, by focusing a global spotlight on influenza mutations and on biotech-based defenses, is creating a new stimulus to develop a universal vaccine and to expand the sectors of the worldwide populace - especially in lower-income regions - that are immunized
You may also be interested in...
Chinese Tank Commanders, Megacity Teens First In Line For A/H1N1 Vaccine
BEIJING - As the Beijing-based Sinovac Biotech ramps up production of the world's first publicly available A/H1N1 vaccine, China's Minister of Health has identified special sectors of the country's 1.3-billion-strong populace that will receive inoculations first, within the next several days
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).